Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Enamel-dentin crown fractures bonded with various bonding agents.

Tandlaegernes nye tidsskrift

Munksgaard EC, Hojtved L, Jorgensen EH, Andreasen JO, Andreasen FM.
PMID: 2069811
Tandlaegernes Tidsskr. 1991 Mar;6(3):76-9.

No abstract available.

Cite
Munksgaard EC, Hojtved L, Jorgensen EH, et al. Enamel-dentin crown fractures bonded with various bonding agents. Tandlaegernes Tidsskr. 1991;6(3):76-9
Munksgaard, E. C., Hojtved, L., Jorgensen, E. H., Andreasen, J. O., & Andreasen, F. M. (1991). Enamel-dentin crown fractures bonded with various bonding agents. Tandlaegernes nye tidsskrift, 6(3), 76-9.
Munksgaard, E C, et al. "Enamel-dentin crown fractures bonded with various bonding agents." Tandlaegernes nye tidsskrift vol. 6,3 (1991): 76-9.
Munksgaard EC, Hojtved L, Jorgensen EH, Andreasen JO, Andreasen FM. Enamel-dentin crown fractures bonded with various bonding agents. Tandlaegernes Tidsskr. 1991 Mar;6(3):76-9. PMID: 2069811.
Copy Download .nbib Format: NLM
A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.

Ecancermedicalscience

Vestermark LW, Holtved E, Dahlrot R, Brimnes MK, Svane IM, Bastholt L.
PMID: 22275974
Ecancermedicalscience. 2008;2:91. doi: 10.3332/ecancer.2008.91. Epub 2008 Aug 15.

BACKGROUND: Central nervous system (CNS) metastases develop in nearly half of patients with advanced melanoma and in 15-20% CNS is the first site of relapse. Median overall survival is short, ranging from two to four months, and one-year survival...

Cite
Vestermark LW, Holtved E, Dahlrot R, et al. A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. Ecancermedicalscience. 2008;2:91doi: 10.3332/ecancer.2008.91.
Vestermark, L. W., Holtved, E., Dahlrot, R., Brimnes, M. K., Svane, I. M., & Bastholt, L. (2008). A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. Ecancermedicalscience, 291. https://doi.org/10.3332/ecancer.2008.91
Vestermark, L W, et al. "A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response." Ecancermedicalscience vol. 2 (2008): 91. doi: https://doi.org/10.3332/ecancer.2008.91
Vestermark LW, Holtved E, Dahlrot R, Brimnes MK, Svane IM, Bastholt L. A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. Ecancermedicalscience. 2008;2:91. doi: 10.3332/ecancer.2008.91. Epub 2008 Aug 15. PMID: 22275974; PMCID: PMC3234039.
Copy Download .nbib Format: NLM
Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study.

Acta oncologica (Stockholm, Sweden)

Achiam MP, Nordsmark M, Ladekarl M, Olsen A, Loft A, Garbyal RS, Larsen MH, Ainsworth AP, Kristensen TS, Dikinis S, Kjær DW, Bæksgaard L, Siemsen M, Nielsen MB, Schlander S, Kramer S, Katballe N, Kruhlikava I, Tabaksblat E, Fisker RV, Mortensen PB, Holtved E, Eckardt J, Detlefsen S, Naujokaite G, Lütken CD.
PMID: 34313177
Acta Oncol. 2021 Sep;60(9):1091-1099. doi: 10.1080/0284186X.2021.1937308. Epub 2021 Jul 27.

BACKGROUND: Decisions regarding tumor staging, operability, resectability, and treatment strategy in patients with esophageal cancer are made at multidisciplinary team (MDT) conferences. We aimed to assess interobserver agreement from four national MDT conferences and whether this would have a...

Cite
Achiam MP, Nordsmark M, Ladekarl M, et al. Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study. Acta Oncol. 2021;60(9):1091-1099doi: 10.1080/0284186X.2021.1937308.
Achiam, M. P., Nordsmark, M., Ladekarl, M., Olsen, A., Loft, A., Garbyal, R. S., Larsen, M. H., Ainsworth, A. P., Kristensen, T. S., Dikinis, S., Kjær, D. W., Bæksgaard, L., Siemsen, M., Nielsen, M. B., Schlander, S., Kramer, S., Katballe, N., Kruhlikava, I., Tabaksblat, E., Fisker, R. V., Mortensen, P. B., Holtved, E., Eckardt, J., Detlefsen, S., Naujokaite, G., & Lütken, C. D. (2021). Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study. Acta oncologica (Stockholm, Sweden), 60(9), 1091-1099. https://doi.org/10.1080/0284186X.2021.1937308
Achiam, Michael Patrick, et al. "Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study." Acta oncologica (Stockholm, Sweden) vol. 60,9 (2021): 1091-1099. doi: https://doi.org/10.1080/0284186X.2021.1937308
Achiam MP, Nordsmark M, Ladekarl M, Olsen A, Loft A, Garbyal RS, Larsen MH, Ainsworth AP, Kristensen TS, Dikinis S, Kjær DW, Bæksgaard L, Siemsen M, Nielsen MB, Schlander S, Kramer S, Katballe N, Kruhlikava I, Tabaksblat E, Fisker RV, Mortensen PB, Holtved E, Eckardt J, Detlefsen S, Naujokaite G, Lütken CD. Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study. Acta Oncol. 2021 Sep;60(9):1091-1099. doi: 10.1080/0284186X.2021.1937308. Epub 2021 Jul 27. PMID: 34313177.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries